The Four Objections We Hear Most Often — and What Four Case Studies Tell Us About Whether They Are Valid.
“We already know our market. We’ve been in it for years.”
The evidence: The textile machinery manufacturer had been in his market for 23 years when the research revealed adjacent revenue he had never seen, a Bangladesh export opportunity he had never considered, and a competitor service crisis he had not detected. The FinTech founders had been operating for 9 months and processing 43 active clients when the research revealed they were winning in a channel they hadn’t noticed and converting at 4x in a segment they were under-investing in.
The reality: Depth of experience in a market creates expertise — but it also creates blind spots. The longer you have been inside a market, the harder it is to see what you are not seeing. External intelligence is not a substitute for your market experience. It is a complement to it — seeing what you cannot see because you are too close.
“We can’t afford research right now. Budget is tight.”
The evidence: The HealthTech founders invested ₹1,75,000 in research with ₹2.1Cr seed capital deployed and 10 months of runway remaining. The research enabled a ₹12Cr raise. The FinTech founders invested ₹2,20,000 with ₹1.05Cr of seed runway remaining. The research enabled a ₹3.5Cr bridge round. In both cases, the research investment happened precisely when the budget was tightest — because the stakes of the decision were highest.
The reality: The moments when the budget is tightest are almost always the moments when the decision stakes are highest. High-stakes decisions made without intelligence are the most expensive decisions a business makes. Research is not a discretionary expense — it is risk mitigation.
“We don’t have time for a research project right now.”
The evidence: The HealthTech founders had 11 days before their investor meeting. They commissioned a 58-page investor-grade report in that window — and it changed the outcome of the meeting. The D2C founder commissioned research 3 weeks before ₹40 lakhs of marketing spend was due to be deployed. The manufacturing SME owner converted competitor accounts within 45 days of research delivery.
The reality: SAI GENiUS’s 5–15 day delivery timelines are designed for the reality of Indian business decision-making — where the ideal timeline is rarely available and the actual timeline is always tight. The research that changes a decision is usually the research commissioned when there seems to be no time for research.
“We’ve commissioned research before, and it wasn’t useful.”
The evidence: The FinTech founders had previously used a freelance research resource whose report they had found too generic to act on. The HealthTech founders had tried to produce their own market sizing and had been challenged on the methodology by their investor. The D2C founder had purchased a syndicated D2C sector report that covered 15 countries and was not useful for a Gujarat-to-national expansion decision.
The reality: Generic research is not useful. Research that was not designed for your specific decision is not useful. Research without methodology documentation is not useful. The SAI GENiUS case studies on this page document research that was designed specifically for the client’s decision, verified against the client’s specific market, and structured with methodology that held up under investor scrutiny. That is a different product from generic syndicated reports and freelance research compilations.
We have many reviews from our satisfied clients.
Kathleen Smith
Van Hunter
Macquarie Telecom
